Christopher Jahnle

Managing DirectorHaverford Healthcare AdvisorsPaoli, PA
Christopher Jahnle

Bio: A Co-Founder and Managing Director of Haverford Healthcare Advisors, Christopher Jahnle has over 30 years of experience providing transaction advisory and business valuation services to enterprises participating in the healthcare services industry. Along with his colleagues at Haverford, Jahnle has served as exclusive financial advisor on over 50 pathology practice/laboratory acquisition transactions and over 35 clinical laboratory acquisition transactions. He has originated and completed transactions across a variety of healthcare service segments, including lab and pathology, with a combined value of more than $2.5 billion.

In 2006, Jahnle co-founded Aurora Diagnostics, LLC which has grown to become a leading national anatomic pathology services company employing over 220 pathologists with annual net revenue in excess of $330 million. From 2006 through 2018, Haverford initiated and completed 37 acquisitions of pathology practices and laboratories on behalf of Aurora Diagnostics as its exclusive acquisition advisor. Aurora Diagnostics was acquired by Sonic Healthcare Ltd. for $540 million effective January 31, 2019.

Jahnle holds a BS in Commerce and Engineering Sciences and an MS in Taxation from Drexel University. He has been an Accredited Senior Appraiser and Member of the American Society of Appraisers, where he has been certified in the specialty of business valuation for over 30 years. Jahnle speaks regularly at industry conferences on valuation issues, mergers and acquisitions, and healthcare service industry trends. He has published articles and been quoted in numerous industry publications and has written industry reports that have been circulated to thousands of healthcare business owners.